Biohope's Angel Round

Biohope raised a round of funding on November 27, 2017. Investors include Capital Cell.

Biohope is dedicated to the development of diagnostic and therapeutic solutions for the immunological clinical management of kidney transplant patients, with potential application to other immune-base…

Articles about Biohope's Angel Round: